Cancer
📧 Sign up to get email alerts when something new happens for Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning [NA]
This document reports on an ongoing clinical trial evaluating a mobile health app (PACT) to improve engagement in advance care planning. The…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs [NA]
An update on ACTIVATE, an AI-driven tool for evaluating clinical-trial information and viability using EHR data, sponsored by the Dana-Farbe…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Can Protein Intake be Increased Using Whole Foods Post-treatment in Cancer Patients? [NA]
A University of Alberta trial evaluated whether protein intake for cancer patients can be increased using whole foods after treatment; the s…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
This update indicates ongoing recruitment for a study at MD Anderson Cancer Center evaluating adherence, health-related quality of life, and…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: The Effect of Sujok Therapy on Patient Comfort, Pain Intensity, and Anxiety Level in Cancer Patients With Port Catheter Placement [NA]
This completed clinical trial evaluated whether Sujok Therapy improves comfort, pain intensity, and anxiety in cancer patients with port cat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors [Phase 1, Phase 2]
Immatics Biotechnologies reports its TCER molecule IMA402 is being evaluated in Phase 1/2 trials for recurrent and/or refractory solid tumor…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors [Phase 1]
First-in-human Phase 1 trial of IDRX-42 for metastatic and/or unresectable gastrointestinal stromal tumors (GIST) is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Wearable Technology and Machine Learning for Early Detection and Risk Assessment of Unacceptable Toxicities in a Paediatric Oncology Cohort
A pediatric cancer trial uses wearable devices and machine learning to detect early signs of unacceptable toxicities and assess toxicity ris…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Preparing for Life and Academics for Young Childhood Cancer Survivors [NA]
This entry highlights a recruiting clinical trial sponsored by Nationwide Children’s Hospital, aimed at helping young survivors of cancer wi…
-
CLINICAL_TRIALS other · 2025-11-17Clinical Trial Update: Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures [NA]
A University of Southern California–sponsored clinical trial testing virtual reality to reduce pain and anxiety in cancer patients undergoin…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2a trial of SQ3370 in patients with advanced solid tumors has been terminated; results have been posted.
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: CesiKids Trial: Enhancing Psychological Resilience in Adolescents With Cancer [NA]
The CesiKids trial, sponsored by Eskisehir Osmangazi University, aims to enhance psychological resilience in adolescents with cancer, potent…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies [Phase 1]
Phase 1 study update of AZD6244 (ARRY-142886) in adults with advanced solid malignancies; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing [NA]
This clinical trial update reports a recruiting study sponsored by the New Mexico Cancer Research Alliance to engage American Indians of Sou…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Cannabis Use Registry to Improve Overall Understanding of Symptoms (CURIOUS)
HealthPartners Institute's CURIOUS cannabis use registry is currently recruiting to better understand cannabis-related symptoms in people wi…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
This clinical trial investigates germ-line mutations in blood and saliva samples from patients with cancer. It is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Monitoring Your Exercise-related Metrics Over Time Via Wearable Electronic Devices [NA]
An update on a clinical trial at MD Anderson investigating exercise metrics tracked by wearable devices in cancer and diabetes patients. The…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer [NA]
A clinical trial is evaluating whether immersive virtual reality can reduce chemotherapy-induced distress in cancer patients and is currentl…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial from MD Anderson is evaluating a combination therapy to treat sleep disturbance in patients with advanced cancer.…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: PC001- A Study to Evaluate the Usability of PointCheck [NA]
The PC001 usability study for PointCheck conducted by Leuko Labs has completed.
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience) [NA]
This clinical trial update describes CAPABLE (CrossFit and Physical Activity: A Better Life Experience), a study examining CrossFit and phys…
-
EMA approval · 2025-11-05EMA Authorised: Ivemend (fosaprepitant) — Merck Sharp & Dohme B.V.
EMA authorised Ivemend (fosaprepitant) by Merck Sharp & Dohme B.V. for prevention of chemotherapy-induced vomiting in cancer patients.
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4 [Phase 1]
A Phase 1 study evaluating the biodistribution and pharmacokinetics of the PET radiopharmaceutical 18F-C SNAT4 for cancer, including lung ca…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI) [NA]
A completed clinical trial evaluating Reiki therapy to improve key symptoms in cancer patients within an integrative oncology clinic.
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: ActivityChoice: Implementing Clinic-Based Physical Activity Program Choices for Cancer Survivors [NA]
Clinical trial update on ActivityChoice, a clinic-based physical activity program for cancer survivors; currently enrolling by invitation.